Overview of Dr. Desai
Dr. Ankit Desai is a cardiologist in Indianapolis, IN and is affiliated with Indiana University Health University Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 14 years. He also speaks multiple languages, including English, Gujarati, Hindi, and Spanish. He specializes in adult heart disease, pulmonary vascular medicine, sickle cell disease, and cardiovascular genetics and is experienced in pulmonary hypertension, sickle-cell anemia, and medical genetics.
Office
1801 N Senate Blvd
# Sutie
Indianapolis, IN 46202Fax+1 317-962-9657- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Cardiovascular Disease, 2008 - 2010
- California Pacific Medical CenterResidency, Internal Medicine, 2003 - 2006
- University of Illinois College of MedicineClass of 2003
Certifications & Licensure
- IN State Medical License 2018 - 2025
- AZ State Medical License 2014 - 2020
- IL State Medical License 2006 - 2014
- CA State Medical License 2003 - 2006
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 28 citationsMendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension.Anna Ulrich, John Wharton, Timothy E. Thayer, Emilia M. Swietlik, Tufik R. Assad
The European Respiratory Journal. 2020-02-12 - 6 citationsGenetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.Leonardo A. Guerra, Christelle Lteif, Meghan J. Arwood, Caitrin W. McDonough, Leanne Dumeny
The Pharmacogenomics Journal. 2021-10-12 - 34 citationsWhole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.Christopher J. Rhodes, Pablo Otero-Núñez, John Wharton, Emilia M. Swietlik, Sokratis Kariotis
American Journal of Respiratory and Critical Care Medicine. 2020-04-30
Press Mentions
- New Insights and Potential Treatments for Pulmonary HypertensionAugust 21st, 2024
- Beta Blocker Used to Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 5th, 2024
- Beta Blocker Used To Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 17th, 2024
Grant Support
- Sickle cell diseaseNHLBI2017–2022
Professional Memberships
- Fellow
- Fellow
- Member
- Pulmonary Hypertension AssociationScientific Leadership Council Member
- Member
- Pulmonary hypertension breakthrough initiativeMember
Other Languages
- Gujarati, Hindi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: